These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36101748)

  • 1. Falsified and substandard medicines trafficking: A wakeup call for the African continent.
    Wada YH; Abdulrahman A; Ibrahim Muhammad M; Owanta VC; Chimelumeze PU; Khalid GM
    Public Health Pract (Oxf); 2022 Jun; 3():100240. PubMed ID: 36101748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review.
    Asrade Mekonnen B; Getie Yizengaw M; Chanie Worku M
    J Pharm Policy Pract; 2024; 17(1):2375267. PubMed ID: 39015754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo.
    Schäfermann S; Hauk C; Wemakor E; Neci R; Mutombo G; Ngah Ndze E; Cletus T; Nyaah F; Pattinora M; Wistuba D; Helmle I; Häfele-Abah C; Gross H; Heide L
    Am J Trop Med Hyg; 2020 Aug; 103(2):894-908. PubMed ID: 32394884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.
    Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y
    JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE
    JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches.
    Ozawa S; Higgins CR; Nwokike JI; Phanouvong S
    Am J Trop Med Hyg; 2022 Jul; 107(1):14-20. PubMed ID: 35895357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on the Development of Methods for Detection of Substandard and Falsified Medicines by Clarifying Their Pharmaceutical Characteristics Using Modern Technology.
    Yoshida N
    Biol Pharm Bull; 2024; 47(5):878-885. PubMed ID: 38692863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review.
    Sorato MM; Davari M; Kebriaeezadeh A
    J Med Access; 2024; 8():27550834241236598. PubMed ID: 38476401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing health system strengthening through improving access to medicines: A review of local manufacturing policies in Ghana.
    Peprah Boaitey K; Tuck C
    Med Access Point Care; 2020; 4():2399202620962299. PubMed ID: 36204087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.
    Pisani E; Nistor AL; Hasnida A; Parmaksiz K; Xu J; Kok MO
    Wellcome Open Res; 2019; 4():70. PubMed ID: 31131333
    [No Abstract]   [Full Text] [Related]  

  • 14. Poor-quality antimalarials further health inequities in Uganda.
    Evans DR; Higgins CR; Laing SK; Awor P; Ozawa S
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii36-iii47. PubMed ID: 31816072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study.
    Ozawa S; Evans DR; Higgins CR; Laing SK; Awor P
    Malar J; 2019 Jan; 18(1):5. PubMed ID: 30626380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substandard drugs: a potential crisis for public health.
    Johnston A; Holt DW
    Br J Clin Pharmacol; 2014 Aug; 78(2):218-43. PubMed ID: 24286459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic impact of substandard and falsified antimalarial medications in Nigeria.
    Beargie SM; Higgins CR; Evans DR; Laing SK; Erim D; Ozawa S
    PLoS One; 2019; 14(8):e0217910. PubMed ID: 31415560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substandard and Falsified Medicines in Myanmar.
    Sakuda M; Yoshida N; Takaoka T; Sanada T; Rahman MS; Tanimoto T; Zin T; Kimura K; Tsuboi H
    Pharmacy (Basel); 2020 Mar; 8(1):. PubMed ID: 32204459
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality of medicines in southern Togo: Investigation of antibiotics and of medicines for non-communicable diseases from pharmacies and informal vendors.
    Schäfermann S; Wemakor E; Hauk C; Heide L
    PLoS One; 2018; 13(11):e0207911. PubMed ID: 30496234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority.
    Mori AT; Meena E; Kaale EA
    BMJ Open; 2018 Jun; 8(6):e021825. PubMed ID: 29950474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.